Klaria Pharma Correlations
| KLAR Stock | SEK 0.40 0.05 14.29% |
The current 90-days correlation between Klaria Pharma Holding and Cyxone AB is -0.08 (i.e., Good diversification). The correlation of Klaria Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Klaria Pharma Correlation With Market
Significant diversification
The correlation between Klaria Pharma Holding and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Klaria Pharma Holding and DJI in the same portfolio, assuming nothing else is changed.
Klaria |
The ability to find closely correlated positions to Klaria Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klaria Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klaria Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klaria Pharma Holding to buy it.
Moving together with Klaria Stock
Moving against Klaria Stock
| 0.72 | SKA-B | Skanska AB | PairCorr |
| 0.68 | ERIC-A | Telefonaktiebolaget | PairCorr |
| 0.65 | SHB-B | Svenska Handelsbanken | PairCorr |
| 0.62 | SHB-A | Svenska Handelsbanken | PairCorr |
| 0.51 | VOLV-B | AB Volvo | PairCorr |
| 0.47 | VOLV-A | AB Volvo | PairCorr |
| 0.4 | SPRINT | Sprint Bioscience | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Klaria Stock performing well and Klaria Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Klaria Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KAN | 4.46 | (0.36) | 0.00 | 0.47 | 0.00 | 11.93 | 48.95 | |||
| CYXO | 6.89 | (0.63) | 0.00 | (0.21) | 0.00 | 14.29 | 90.37 | |||
| LIDDS | 8.69 | 0.72 | 0.04 | 1.36 | 9.80 | 20.00 | 64.77 | |||
| CANTA | 3.01 | (0.55) | 0.00 | 0.23 | 0.00 | 4.47 | 47.04 | |||
| XINT | 3.27 | (0.73) | 0.00 | 0.73 | 0.00 | 6.06 | 18.88 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Klaria Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Klaria Pharma Corporate Management
Elected by the shareholders, the Klaria Pharma's board of directors comprises two types of representatives: Klaria Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Klaria. The board's role is to monitor Klaria Pharma's management team and ensure that shareholders' interests are well served. Klaria Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Klaria Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hans MD | Chief Officer | Profile | |
| Hans Richter | Chief Consultative | Profile | |
| Susan Suchdev | Chief Officer | Profile | |
| Fredrik Hubinette | Chairman CTO | Profile | |
| Marc Willuhn | Manufacturing Chemistry | Profile | |
| Jesper Wiklund | Chief Officer | Profile |